MedTrace Logo

Community Salt Testing and Relation of Iodine Intake to Visual Information Processing of Ethiopian Infants

NCT03889431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2019-03-26

No results posted yet for this study

Summary

This study evaluated efficacy of iodized salt for mothers and their six-month-old infants' thyroid hormones and visual information processing. Half of the participants received 450 g iodized salt for the household each week, while the other half received 225 ug iodine daily as a potassium iodide capsule.

Conditions

  • Iodine Deficiency Goiter
  • Infant Development

Interventions

DIETARY_SUPPLEMENT

Iodine capsule

225 µg of iodine daily as a capsule of potassium iodide

OTHER

Iodized Salt

450 g iodized salt provided for the household weekly. Salt iodine content was 30 to 40 mg iodine /kg salt as KIO3

Sponsors & Collaborators

  • Oklahoma State University

    lead OTHER

Principal Investigators

  • Tafere Gebreegziabher, PhD · Central Washington University & Hawassa University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-02
Primary Completion
2013-01-30
Completion
2013-08-10

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03889431 on ClinicalTrials.gov